PT-Cy combined with ruxolitinib and tocilizumab prevents aGVHD after haploidentical HSCT

PT-Cy combined with ruxolitinib and tocilizumab prevents aGVHD after haploidentical HSCT

Objective To evaluate the efficacy of post-transplant cyclophosphamide (PT-Cy) combined with ruxolitinib and tocilizumab in the prevention of acute graft versus host disease (aGVHD) after haploidentical allogeneic peripheral blood hematopoietic stem cell transplantation (HSCT) by a single-arm prospe...

Full description

Bibliographic Details
Main Authors: BAI Haocheng, FENG Jing, WANG Sanbin
Format: Article
Language:zho
Published: Editorial Office of Journal of Third Military Medical University 2020-09-01
Series:Di-san junyi daxue xuebao
Subjects:
acute graft-versus-host disease
allogeneic peripheral blood hematopoietic stem cells
haplotype congruence
ruxolitinib
tocilizumab
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202006155.htm

Internet

http://aammt.tmmu.edu.cn/Upload/rhtml/202006155.htm

Similar Items